|
Showing the most relevant articles for your search:NASDAQ:SQNM Date | Time | Source | Headline | Symbol | Company | 08/01/2014 | 6:32AM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:SQNM | Sequenom, Inc. |
07/29/2014 | 4:31PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SQNM | Sequenom, Inc. |
07/29/2014 | 4:10PM | PR Newswire (US) | Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 | NASDAQ:SQNM | Sequenom, Inc. |
07/29/2014 | 4:10PM | PR Newswire (US) | Sequenom Enters Into License Agreement With Mayo Medical Laboratories | NASDAQ:SQNM | Sequenom, Inc. |
07/22/2014 | 7:00AM | PR Newswire (US) | Sequenom Laboratories Presents New Data on the Enhanced Sequencing Series for the MaterniT21™ Plus Laboratory-Developed Tes... | NASDAQ:SQNM | Sequenom, Inc. |
07/21/2014 | 7:00AM | PR Newswire (US) | Sequenom Laboratories Expands International Noninvasive Prenatal Testing Services To Broader Population With VisibiliT™ Test | NASDAQ:SQNM | Sequenom, Inc. |
07/15/2014 | 7:00AM | PR Newswire (US) | Sequenom, Inc. Announces Date Of Second Quarter 2014 Financial Results And Conference Call | NASDAQ:SQNM | Sequenom, Inc. |
06/23/2014 | 11:33AM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:SQNM | Sequenom, Inc. |
06/19/2014 | 7:00AM | PR Newswire (US) | Nicox and Sequenom announce the launch of expanded access to RetnaGene™ test portfolio in the U.S. | NASDAQ:SQNM | Sequenom, Inc. |
06/16/2014 | 8:59AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SQNM | Sequenom, Inc. |
06/16/2014 | 8:00AM | PR Newswire (US) | Sequenom, Inc. Receives U.S. FDA Premarket Clearance | NASDAQ:SQNM | Sequenom, Inc. |
06/16/2014 | 8:00AM | PR Newswire (US) | Sequenom Laboratories and Quest Diagnostics Collaborate to Expand Patient Access to the MaterniT21™ PLUS Noninvasive Prenat... | NASDAQ:SQNM | Sequenom, Inc. |
06/11/2014 | 4:07PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SQNM | Sequenom, Inc. |
06/09/2014 | 7:00AM | PR Newswire (US) | Sequenom Laboratories Announces Third National Coverage Agreement For Prenatal Diagnostic Testing Services | NASDAQ:SQNM | Sequenom, Inc. |
06/04/2014 | 6:01AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SQNM | Sequenom, Inc. |
06/03/2014 | 12:31PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SQNM | Sequenom, Inc. |
05/30/2014 | 4:30PM | PR Newswire (US) | Sequenom, Inc.'s Bioscience Business Acquired by Agena Bioscience, a Telegraph Hill Partners Portfolio Company | NASDAQ:SQNM | Sequenom, Inc. |
05/30/2014 | 4:30PM | PR Newswire (US) | Sequenom, Inc. Reports Sale Of Bioscience Business | NASDAQ:SQNM | Sequenom, Inc. |
05/30/2014 | 12:51PM | Edgar (US Regulatory) | Specialized Disclosure Report (sd) | NASDAQ:SQNM | Sequenom, Inc. |
05/27/2014 | 7:00AM | PR Newswire (US) | Sequenom, Inc. Announces Participation At The Jefferies 2014 Global Healthcare Conference | NASDAQ:SQNM | Sequenom, Inc. |
05/02/2014 | 6:07AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SQNM | Sequenom, Inc. |
05/01/2014 | 4:10PM | PR Newswire (US) | Sequenom, Inc. Reports Financial Results For The First Quarter Of 2014 | NASDAQ:SQNM | Sequenom, Inc. |
04/29/2014 | 9:37AM | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:SQNM | Sequenom, Inc. |
04/25/2014 | 8:14AM | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:SQNM | Sequenom, Inc. |
04/25/2014 | 8:01AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:SQNM | Sequenom, Inc. |
04/17/2014 | 7:00AM | PR Newswire (US) | Sequenom, Inc. Announces Date Of First Quarter 2014 Financial Results And Conference Call | NASDAQ:SQNM | Sequenom, Inc. |
04/14/2014 | 6:13AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SQNM | Sequenom, Inc. |
03/21/2014 | 5:00PM | PR Newswire (US) | Sequenom and Former CFO Resolve Litigation | NASDAQ:SQNM | Sequenom, Inc. |
03/20/2014 | 8:33AM | PR Newswire (US) | Technical Notes on Top Gainers -- Research on Sequenom, ImmunoCellular Therapeutics, Intellicheck Mobilisa, and La Jolla Pharma | NASDAQ:SQNM | Sequenom, Inc. |
03/06/2014 | 6:01AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SQNM | Sequenom, Inc. |
|
Showing the most relevant articles for your search:NASDAQ:SQNM |
|